go back

SQUALENE SYNTHASE DEFICIENCY

SQUALENE SYNTHASE DEFICIENCY
NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS
618156
OMIM = Online Mendelian Inheritance of Men
Squalene synthase
2.5.1.21
very rare
autosomal recessive
mutations in the FDFT1 gene
2-3 syndactyly of the toes, and facial dysmorphisms, resembling Smith-Lemli-Opitz syndrome [Coman D 2018, 2020]
Laboratory findings2-Methylfumaric acid inc (urine)
3-Methyladipic acid inc (urine)
Cholestanol dec (plasma)
Cholesterol decreased (plasma)
Triglycerides normal (serum)
   2-Methylsuccinic acid inc (urine)
    1-Methylhydantoin inc (urine)
    2-Methylfumaric acid inc (urine)
    Deoxycorticosterone inc (urine)
    Farnesol inc (plasma)
    Mevalonolactone inc (urine)
    Squalene normal/dec (plasma)
    Squalene inc (urine)
Symptoms   developmental delay
   dysmorphism
   irritability
   seizures
   skeletal changes, skeletal abnormalities
   white matter changes, abnormalities
    behavior, autism or autistic-like
    blindness, visual loss, visual impairment
    brain malformation
    cryptorchism
    failure to thrive
    genital malformation
    heart involvement
    hyperreflexia
    hypersalivation
    hypoplasia of optic nerve or disk
    hypospadia
    intellectual disability/intellectual developmental disorder
    liver involvement or dysfunction
    low birthweight (small for gestational age)
    onset, infancy
    onset, neonatal
    photophobia or photosensitive defect in light-exposed area
    skin, abnormal
    syndactyly